608 filings
8-K
FWBI
First Wave BioPharma Inc
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
4
FWBI
First Wave BioPharma Inc
19 Mar 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:13pm
4
FWBI
First Wave BioPharma Inc
19 Mar 24
First Wave BioPharma / Sarah Romano ownership change
4:10pm
8-K
FWBI
First Wave BioPharma Inc
18 Mar 24
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
4:40pm
DEFA14A
FWBI
First Wave BioPharma Inc
18 Mar 24
Additional proxy soliciting materials
4:31pm
4
bnd09uk 62o
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:05pm
4
zdzzr aw5e9r4y
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:05pm
3
1gax85ntj8b2tfp8
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:00pm
3
macfb
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:00pm
DEFA14A
solq4937l5lauagrc
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
v19t4j12olbvfu
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
fw23cgnm36e1qmlbldf2
5 Mar 24
First Wave BioPharma, Inc. to raise approximately $4.0 million of Gross Proceeds in Registered Direct Offering
5:26pm
424B5
ecfqra
4 Mar 24
Prospectus supplement for primary offering
5:29pm
SC 13G/A
2894fssx6eb8s48w
14 Feb 24
First Wave BioPharma / ARMISTICE CAPITAL ownership change
2:45pm
424B3
08vbm
18 Jan 24
Prospectus supplement
4:01pm
EFFECT
a274p89rfwemq3br me7
18 Jan 24
Notice of effectiveness
12:15am
4
yej60dr9t2c9bhzl
17 Jan 24
First Wave BioPharma / Sarah Romano ownership change
4:02pm
4
arowras1cyq ck8mi
17 Jan 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:01pm
CORRESP
vxr b6nw2ceytyx92u
16 Jan 24
Correspondence with SEC
12:00am
UPLOAD
a0x0wjw5frttr0s4w2
12 Jan 24
Letter from SEC
12:00am